Adam Frymoyer

Back to Profile

Publication Details

  • Nevirapine pharmacokinetics and risk of rash and hepatitis among HIV-infected sub-Saharan African women.

    Dong BJ, Zheng Y, Hughes MD, Frymoyer A, Verotta D, Lizak P, Sawe F, Currier JS, Lockman S, Aweeka FT. AIDS. 2012; 26 (7): 833-41

    To estimate nevirapine (NVP) pharmacokinetics and examine its association with rash and/or hepatotoxicity in women starting antiretroviral treatment in the AIDS Clinical Trials Group A5208/OCTANE study in Africa.

    PubMedID: 22301417

Stanford Medicine Resources:

Footer Links: